(Q48328230)

10 February 2018

http://europepmc.org/abstract/MED/28581516

title

Pancreatic cancer heterogeneity and response to Mek inhibition (English)

1 reference

10 February 2018

http://europepmc.org/abstract/MED/28581516

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Daniel Massó-Vallés

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ana Vivancos

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Joaquim Balsells

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Laura Soucek

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Josep Tabernero Caturla

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Joaquin Arribas

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

K Pedersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

F Bilal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C Bernadó Morales

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M T Salcedo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

T Macarulla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

V Mohan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M-J Carreras

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

X Serres

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Abu-Suboh

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

E Allende

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

I Sagi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

5 June 2017

1 reference

10 February 2018

http://europepmc.org/abstract/MED/28581516

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

5639-5647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581516%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2017.174

13 June 2020

exact match

0 references

cites work

Pancreatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Characterizing DNA methylation alterations from The Cancer Genome Atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

The promise of patient-derived xenografts: the best laid plans of mice and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Cancer heterogeneity: implications for targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Pancreatic cancer stroma: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.174